Colossal Biosciences is pursuing “de-extinction” using advanced genetic engineering techniques to recreate extinct animals, with an early focus on dire wolves and longer-term plans for woolly mammoths. The company highlights recent work in which it recreates dire wolf embryos by combining DNA information drawn from ancient fossil material with gray wolf cells.
Across coverage, the stated goals extend beyond restoring specific species. The company frames de-extinction as a way to support conservation efforts, including potential ecological benefits such as helping preserve Arctic permafrost. CNBC also quotes CEO Ben Lamm, who links the work to broader scientific value, saying the approach could contribute to areas such as developmental biology and healthcare, alongside conservation.
While the reports emphasize different potential impacts—ecological outcomes in one case and possible human health relevance in another—they both describe Colossal’s ongoing efforts to develop workable methods for bringing extinct species back using modern laboratory tools and genetic approaches.
